| 1 | 10% intravenous immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 |
| 2 | 10% liquid formulation of human immunoglobulin | - | - | - | - | [1] 14 14 |
| 3 | : immunoglobulina umana normale 10% per somministrazione endovenosa | - | - | - | - | [1] 14 14 |
| 4 | Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain) | - | - | - | - | [1] 271 271 |
| 5 | Anti-human immunoglobulin, equine | - | - | - | - | [1] 60 60 |
| 6 | Anti-human T-lymphocyte immunoglobulin from horse | - | - | - | - | [1] 60 60 |
| 7 | ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS | - | - | - | - | [1] 51 51 |
| 8 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | [2] 96 96, 97 |
| 9 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | [2] 96 96, 97 |
| 10 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [2] 96 96, 97 |
| 11 | Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2) | - | - | - | - | [1] 96 96 |
| 12 | ANTITHYMOCYTE IMMUNOGLOBULIN | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [2] 13 13, 96 |
| 13 | Antithymocyte immunoglobulin (rabbit) | [2] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [2] 13 13, 96 |
| 14 | Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 |
| 15 | Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 |
| 16 | Chemical conjugate of recombinant human growth hormone (rhGH) and human immunoglobulin G4 fragment (HMC001) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
| 17 | Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | [1] Denosumab Denosumab | [1] D03684
D03684
| [1] TNFSF11 TNFSF11 💬 | [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 |
| 18 | Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | [1] Denosumab Denosumab | [1] D03684
D03684
| [1] TNFSF11 TNFSF11 💬 | [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 |
| 19 | Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 43, 45 |
| 20 | Gammaplex (Intravenous immunoglobulin) | - | - | - | - | [1] 65 65 |
| 21 | Gammaplex, intravenous immunoglobulin | - | - | - | - | [1] 63 63 |
| 22 | GB-0998 (Intravenous immunoglobulin) | - | - | - | - | [1] 11 11 |
| 23 | High-dose intravenous immunoglobulin (IVIG) | - | - | - | - | [1] 18 18 |
| 24 | High-dose intravenous immunoglobulin (Venoglobulin-IH) | - | - | - | - | [1] 51 51 |
| 25 | Human Immunoglobulin | - | - | - | - | [2] 63 63, 65 |
| 26 | HUMAN IMMUNOGLOBULIN G | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 14 14, 50, 63, 65 |
| 27 | Human normal 10% immunoglobulin for intravenous administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 |
| 28 | Human normal 10% immunoglobulin for intravenous administrationn | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 |
| 29 | Human normal immunoglobulin | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [9] 11 11, 13, 14, 43, 45, 50, 51, 63, 65 |
| 30 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 11 11, 14, 63, 65 |
| 31 | Human normal immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 50, 65 |
| 32 | Human normal immunoglobulin (SCIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 |
| 33 | Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
| 34 | Human normal immunoglobulin (subcutaneous) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
| 35 | HUMAN NORMAL IMMUNOGLOBULIN FOR | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
| 36 | Human normal immunoglobulin for intravenous (IV) administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 51 51 |
| 37 | Human normal immunoglobulin for intravenous administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 51, 65 |
| 38 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 63 63, 65 |
| 39 | Human normal immunoglobulin for intravenous use (IVIG) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
| 40 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 63 63 |
| 41 | Human normal immunoglobulin for subcutaneous administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 51 51, 65 |
| 42 | Human Normal Immunoglobulin for Subcutaneous Administration (IGSC) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
| 43 | Human normal immunoglobulin G (IgG > 98% purity) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 63, 65 |
| 44 | Human normal immunoglobulin G (IgG) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 |
| 45 | Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody | - | - | - | - | [1] 46 46 |
| 46 | I.v. immunoglobulins | - | - | - | - | [1] 151 151 |
| 47 | Immunoglobulin | - | - | - | - | [3] 13 13, 14, 63 |
| 48 | Immunoglobulin (Hizentra) | - | - | - | - | [1] 50 50 |
| 49 | IMMUNOGLOBULIN G | - | - | - | - | [8] 2 2, 11, 13, 14, 49, 50, 63, 65 |
| 50 | Immunoglobulin G (Ig NextGen 16%) | - | - | - | - | [1] 65 65 |
| 51 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy | - | - | - | - | [1] 2 2 |
| 52 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer | - | - | - | - | [1] 2 2 |
| 53 | Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer | - | - | - | - | [1] 49 49 |
| 54 | Immunoglobulin intravenous (human) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
| 55 | Immunoglobulin perfusion | - | - | - | - | [1] 14 14 |
| 56 | Immunoglobulina normale umana | - | - | - | - | [1] 51 51 |
| 57 | Immunoglobulina Normale Umana per somministrazione endovenosa | - | - | - | - | [1] 51 51 |
| 58 | Immunoglobulina Normale Umana per somministrazione sottocutanea | - | - | - | - | [1] 51 51 |
| 59 | IMMUNOGLOBULINA UMANA NORMALE | - | - | - | - | [2] 51 51, 65 |
| 60 | IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa | - | - | - | - | [1] 14 14 |
| 61 | Immunoglobuline G | - | - | - | - | [1] 14 14 |
| 62 | Immunoglobulins | - | - | - | - | [1] 14 14 |
| 63 | Immunoglobulins Intravenous (Human) | - | - | - | - | [1] 65 65 |
| 64 | Immunoglobulins, normal human | - | - | - | - | [1] 65 65 |
| 65 | Immunoglobulins, normal human, for extravascular adm. | - | - | - | - | [1] 14 14 |
| 66 | Immunoglobulins, normal human, for intravascular adm. | - | - | - | - | [2] 14 14, 15 |
| 67 | Intravenous Immunoglobulin | - | - | - | - | [8] 13 13, 14, 35, 38, 39, 49, 51, 309 |
| 68 | Intravenous immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 14 14, 17, 164, 296 |
| 69 | Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 |
| 70 | Intravenous immunoglobulin infusion | - | - | - | - | [1] 65 65 |
| 71 | Intravenous immunoglobulins (human immunoglobulins G) | - | - | - | - | [1] 43 43 |
| 72 | L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [1] 13 13 |
| 73 | Normal human immunoglobulin G | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 65 65 |
| 74 | Rabbit anti-human thymocyte immunoglobulin | [2] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [2] 13 13, 96 |
| 75 | RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN | [1] Rabbit Rabbit | - | - | - | [2] 13 13, 60 |
| 76 | Serum bovine immunoglobulin | - | - | - | - | [2] 96 96, 97 |
| 77 | Subcutaneous immunoglobulin | - | - | - | - | [1] 14 14 |
| 78 | Subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 |
| 79 | Subcutaneous immunoglobulins | - | - | - | - | [1] 11 11 |
| 80 | Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 |